1
2
1
| API | inoa mea kūʻai | CAS NO. | Hoʻokaʻina |
| Sotagliflozin | 4-Iodo-1-chloro-2- (4-ethoxybenzyl) benzene | 1103738-29-9 | diabetes |
| Sotagliflozin | D-xylo-Pentodialdo-5,2-furanose, 4,5-O- (1-Methylethylidene) -1-C-4-Morpholinyl -, (5S) - | 1103738-19-7 | diabetes |
| Sotagliflozin | D-xylo-Pentodialdo-5,2-furanose, 1-C- [4-chloro-3 - [(4-ethoxyphenyl) Methyl] phenyl] -4,5-O- (1-Methylethylidene) -, (5S) - | 1103738-30-2 | diabetes |
| Sotagliflozin | 5-bromo-2-chloro-4'-ethoxydiphenylmethane | 461432-23-5 | diabetes |
| Canagliflozin | 2- (4-FLUOROPHENYL) THIOPHENE | 58861-48-6 | diabetes |
| Canagliflozin | 5-Bromo-2-methylbenzoic acid | 79669-49-1 | diabetes |
| Canagliflozin | 2- (4-Fluorophenyl) -5 - [(5-iodo-2-methylphenyl) methyl] thiophene | 898566-17-1 | diabetes |
| ʻO Empagliflozin | (3S) -3- [4 - [(5-Bromo-2-chlorophenyl) methyl] phenoxy] tetrahydro-furan | 915095-89-5 | diabetes |
| Linagliptin | 8-bromo-7- (but-2-ynyl) -3-methyl-1H-purine-2,6 (3H, 7H) -dione | 666816-98-4 | diabetes |
| Linagliptin | 2- (chloromethyl) -4-methylquinazoline | 109113-72-6 | diabetes |
| Linagliptin | 8-Bromo-7-but-2-ynyl-3-methyl-1- (4-methyl-quinazolin-2-ylmethyl) -3,7-dihydro-purine-2,6-dione | 853029-57-9 | diabetes |
| ʻO Sakaliptona | (1S, 3S, 5S) -3- (Aminocarbonyl) -2-azabicyclo [3.1.0] hexane-2-carboxylic acid tert-butyl ester | 361440-67-7 | diabetes |
| ʻO Sakaliptona | (alphaS) -alpha - [[(1,1-Dimethylethoxy) carbonyl] amino] -3-hydroxytricyclo [3.3.1.13,7] decane-1-acetic acid | 361442-00-4 | diabetes |
| ʻO Sitagliptin | 2,4,5-Trifluorophenylacetic acid | 209995-38-0 | diabetes |
| ʻO Sitagliptin | Boc- (R) -3-Amino-4- (2,4,5-Trifluoro-Phenyl) -Butyric Acid | 486460-00-8 | diabetes |
2
| API | inoa mea kūʻai | CAS NO. | Hoʻokaʻina |
| ʻO Sitagliptin | 3- (Trifluoromethyl) -5,6,7,8-tetrahydro- [1,2,4] triazolo [4,3-a] pyrazine hydrochloride | 762240-92-6 | diabetes |
| ʻO Vildagliptin | L-Prolinamide | 7531-52-4 | diabetes |
| ʻO Vildagliptin | (2S) -1- (Chloroacetyl) -2-pyrrolidinecarbonitrile | 207557-35-5 | diabetes |
| ʻO Empagliflozin | 2,3,4,6-Tetrakis-O-trimethylsilyl-D-gluconolactone | 32384-65-9 | diabetes |
| ʻO Vildagliptin | L-Prolinamide | 7531-52-4 | diabetes |